Switch theme
Sign up to access all valuation multiples
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
2008
86
LTM Revenue $7.5M
LTM EBITDA -$29.4M
$44.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
InspireMD has a last 12-month revenue of $7.5M and a last 12-month EBITDA of -$29.4M.
In the most recent fiscal year, InspireMD achieved revenue of $7.0M and an EBITDA of -$33.2M.
InspireMD expects next 12-month revenue of XXX and NTM EBITDA of XXX
See InspireMD valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $6.2M | $7.0M | XXX | XXX | XXX |
| Gross Profit | $1.1M | $1.8M | XXX | XXX | XXX |
| Gross Margin | 18% | 26% | XXX | XXX | XXX |
| EBITDA | -$20.9M | -$33.2M | XXX | XXX | XXX |
| EBITDA Margin | -337% | -474% | XXX | XXX | XXX |
| Net Profit | -$18.5M | -$19.9M | XXX | XXX | XXX |
| Net Margin | -298% | -284% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, InspireMD's stock price is $3.
InspireMD has current market cap of $77.2M, and EV of $44.9M.
See InspireMD trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $44.9M | $77.2M | XXX | XXX | XXX | XXX | $-0.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, InspireMD has market cap of $77.2M and EV of $44.9M.
InspireMD's trades at 6.0x LTM EV/Revenue multiple, and -1.5x LTM EBITDA.
Analysts estimate InspireMD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for InspireMD and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $44.9M | XXX | XXX | XXX |
| EV/Revenue | 6.4x | XXX | XXX | XXX |
| EV/EBITDA | -1.4x | XXX | XXX | XXX |
| P/E | -2.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -1.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpInspireMD's NTM/LTM revenue growth is 76%
InspireMD's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, InspireMD's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate InspireMD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for InspireMD and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -474% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 59% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -398% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 87% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 218% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 195% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 499% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
InspireMD acquired XXX companies to date.
Last acquisition by InspireMD was XXXXXXXX, XXXXX XXXXX XXXXXX . InspireMD acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was InspireMD founded? | InspireMD was founded in 2008. |
| Where is InspireMD headquartered? | InspireMD is headquartered in United States of America. |
| How many employees does InspireMD have? | As of today, InspireMD has 86 employees. |
| Who is the CEO of InspireMD? | InspireMD's CEO is Mr. Marvin Slosman. |
| Is InspireMD publicy listed? | Yes, InspireMD is a public company listed on NAS. |
| What is the stock symbol of InspireMD? | InspireMD trades under NSPR ticker. |
| When did InspireMD go public? | InspireMD went public in 1997. |
| Who are competitors of InspireMD? | Similar companies to InspireMD include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of InspireMD? | InspireMD's current market cap is $77.2M |
| What is the current revenue of InspireMD? | InspireMD's last 12-month revenue is $7.5M. |
| What is the current EBITDA of InspireMD? | InspireMD's last 12-month EBITDA is -$29.4M. |
| What is the current EV/Revenue multiple of InspireMD? | Current revenue multiple of InspireMD is 6.0x. |
| What is the current EV/EBITDA multiple of InspireMD? | Current EBITDA multiple of InspireMD is -1.5x. |
| What is the current revenue growth of InspireMD? | InspireMD revenue growth between 2023 and 2024 was 13%. |
| Is InspireMD profitable? | Yes, InspireMD is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
